Search results for: “Biopharmaceutical”
-
Windtree Therapeutics acquires Varian Biopharmaceuticals’ assets
•
Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the acquisition of a novel oncology asset platform from Varian Biopharmaceuticals,…
-
How Large Is The Biopharmaceutical Industry?
•
The biopharmaceutical industry’s business models are anticipated to be altered during the next two decades by five forces,…
-
PureTech’s Seaport Therapeutics announces an oversubscribed $225 million Series B financing round
•
LONDON: PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) noted that its founded entity, Seaport Therapeutics, a biopharmaceutical company…
-
Aptamer signs agreement to explore Optimer vehicles for targeted delivery of siRNA
•
LONDON: Aptamer Group plc (AIM: APTA) announced a new agreement with AstraZeneca, a global biopharmaceutical company, to evaluate…
-
Syncona Ltd adds iOnctura and Yellowstone Biosciences to it’s portfolio
•
LONDON: Syncona Ltd has added two new companies to its portfolio, iOnctura and Yellowstone Biosciences. Syncona has invested…
-
AstraZeneca to deliver $80 billion revenue by 2030
•
LONDON: AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8…
-
AstraZeneca announces $1.5 billion investment in Singapore manufacturing
•
LONDON: AstraZeneca has unveiled plans to construct a state-of-the-art manufacturing facility in Singapore, dedicated to the production of…
-
Lycia Therapeutics completes $106.6 million Series C financing
•
LONDON: RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company focused on identifying transformative assets with high…
-
Arecor and Medtronic announce diabetes collaboration
•
CAMBRIDGE, UK: Arecor Therapeutics plc, a trailblazer in biopharmaceuticals, has joined hands with healthcare technology titan Medtronic plc…
-
Soleno Therapeutics announces $138 million public offering
•
Soleno Therapeutics, Inc. (Nasdaq: SLNO), a pioneering biopharmaceutical company in the rare disease sector, has declared the launch…
-
LBT Innovations strikes $0.7M deal with NovaCina for APAS Independence Instrument
•
Adelaide, Australia: LBT Innovations Limited, a pioneer in AI-driven microbiology automation, has announced a significant contract with NovaCina,…
-
Angle plc signs new commercial agreement with AstraZeneca
•
LONDON: ANGLE plc (AIM:AGL), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.